Current Literature References on Clinical Pharmacokinetics
Series 1
Pharmacokinetics and clinical response to tricyclic antidepressants. Gram, L.F.: Acta Psychiatrica Scandinavica 61: 169 (1980).
Pharmacokinetic-hemodynamic studies of nitroglycerin ointment in congestive heart failure. Armstrong, P.W. et al.: American Journal of Cardiology 46: 670 (1980)
Pharmacokinetic study of lorazepam overdosage. Allen, M.D. et al.: American Journal of Psychiatry 137: 1414 (1980).
Pharmacokinetics of ketamine in the pediatric surgical patient. Allen, P.D. et al.: Anesthesiology 53: 333S (1980).
Digoxin pharmacokinetics in continuous peritoneal dialysis. Pancorbo, S. et al.: Annals of Internal Medicine 93: 639 (1980).
Increased alpha-1-acid glycoprotein and lidocaine disposition in myocardial infarction. Routledge, P.A. et al.: Annals of Internal Medicine 93: 701 (1980).
Pharmacokinetics of cefmetazole in normal subjects and in patients with impaired renal function. Ohkawa, N. et al.: Antimicrobial Agents and Chemotherapy 18: 386 (1980).
Independence of etozolin elimination of kidney function/single dose experiments in patients with renal insufficiency. Knauf, H. et al.: Arzneimittel-Forschung 30: 1791 (1980).
The pharmacokinetics of cyclophosphamide, phosphoramide mustard and non-nitrogen mustard studied by gas chromatography in patients receiving cyclophosphamide therapy. Juma, F.D. et al.: British Journal of Clinical Pharmacology 10: 327 (1980).
Lignocaine and indocyanine green kinetics in patients following myocardial infarction. Bax, N.D.S. et al.: British Journal of Clinical Pharmacology 10: 353 (1980).
Antipyrine metabolite formation in children in the acute phase of malnutrition and after recovery. Buchanan, N. et al.: British Journal of Clinical Pharmacology 10: 363 (1980).
Penetration of N-(phosphonacetyl)-L-aspartate into human central nervous system and intracerebral tumor. Stewart, D.J. et al.: Cancer Research 40: 3163 (1980).
Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure (special emphasis on antibiotics and β -adrenoceptor blocking agents). Fabre, J. et al.: Clinical Pharmacokinetics 5: 441 (1980).
Change in transfer rate of methotrexate from spinal fluid to plasma during intrathecal therapy in children and adults. Lankelma, J. et al.: Clinical Pharmacokinetics 5: 465 (1980).
The influence of renal function on plasma concentration, urinary excretion and antihypertensive effect of guanfacine. Kirch, W. et al.: Clinical Pharmacokinetics 5: 476 (1980).
Clinical pharmacokinetics in newborns and infants. Morselli, P.L. et al.: Clinical Pharmacokinetics 5: 485 (1980).
Hepatic disease and drug pharmacokinetics. Williams, R.L. et al.: Clinical Pharmacokinetics 5: 528 (1980).
Propoxyphene and norpropoxyphene plasma concentrations after oral propoxyphene in cirrhotic patients with and without surgically constructed portacaval shunt. Giacomini, K.M. et al.: Clinical Pharmacology and Therapeutics 28: 417 (1980).
Massive Propranolol metabolite retention during maintenance hemodialysis. Stone, W.J. and Walle, T.: Clinical Pharmacology and Therapeutics 28: 449 (1980).
Mezlocillin pharmacokinetics in renal impairment. Aronoff, G.R.; Sloan, R.S.; Luft, F.C. et al.: Clinical Pharmacology and Therapeutics 28: 523 (1980).
Low serum valproic acid concentrations in epileptic patients on combination therapy. Reunanen, M.; Luoma, P. and Myllyla, V.V.: Current Therapeutic Research 28: 456 (1980).
Side effects of thioridazine and their relationship with the serum concentrations of the drug and its main metabolites. Axelsson, R. and Martensson, E.: Current Therapeutic Research 28: 463 (1980).
Disposition of dibekacin in patients undergoing haemodialysis. Campillo, J.A.; Lanao, J.M.; Dominguez-Gil, A. et al.: European Journal of Clinical Pharmacology 18: 347 (1980).
Pharmacokinetics of atenolol and its clinical consequences in patients with angina pectoris. Van der Vijgh, W.J.F.; Majid, P.A.; de Feyter, P. et al.: International Journal of Clinical Pharmacology Therapy and Toxicology 18: 375 (1980).
Vancomycin pharmacokinetics. Baker, D.; Rotschafer, J.C.; Sawchuk, R. et al.: Journal of Pediatrics 97: 502 (1980).
Sulfisoxazole secretion into human milk. Kauffman, R.E.; O’Brien, C. and Gilford, P.: Journal of Pediatrics 97: 839 (1980).
Antithyroid drugs in milk. Tegler, L. and Lindstrom, B.: Lancet 2: 591 (1980).
Naproxen levels in preterm infants after maternal treatment. Wilkinson, A.R.: Lancet 2: 591 (1980).
Skeletal uptake of diphosphonate. Fogelman, I.; Bessent, R.G.; Cohen, H.N. et al.: Lancet 2: 667 (1980).
Effect of age on serum salicylate metabolite concentrations in patients receiving chronic acetylsalicylic acid (ASA) therapy. Sitar, D.S. and Montgomery, P.R.: Pharmacologist 22: 190 (1980).
Excretion of pethidine in mothers milk. Peiker, G.; Muller, B.; Ihn, W. et al.: Zentralblatt für Gynakologie 102: 537 (1980).
Rights and permissions
About this article
Cite this article
Current Literature References on Clinical Pharmacokinetics. Clin Pharmacokinet 6, 160 (1981). https://doi.org/10.2165/00003088-198106020-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198106020-00006